Bullish
EU approves Arrowhead's REDEMPLO for rare fat disorder FCS
Arrowhead Pharmaceuticals has received marketing authorization from the European Commission (EC) for REDEMPLO (plozasiran) to treat Familial Chylomicr...
ARWR
--
--
--
--
Price Chart (30 Days)
Ad Space
Analyst Sentiment
Bullish (1)
Neutral (0)
Bearish (0)
Latest ARWR News
Research ARWR on:
Ad Space